ICON Public Limited Company

NasdaqGS:ICLR

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

🧬 Biotechnology

💻 Telehealth

Location

Ireland

Market Cap

USD 11.41 B

Share Price

USD 143.58

Avg Daily Volume

1,488,263

Change (1 day)

1.21%

Change (1 year)

-54.94%

Change (YTD)

-31.53%

ICON Public Limited Company Market Capitalization on June 18, 2025: USD 11.41 B

ICON Public Limited Company Market Capitalization is USD 11.41 B on June 18, 2025, a -56.49% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

ICON Public Limited Company 52-week low Market Capitalization is USD 28.50 B on June 18, 2025, which is 149.75% above the current Market Capitalization.
ICON Public Limited Company 52-week low Market Capitalization is USD 10.06 B on June 18, 2025, which is -11.81% below the current Market Capitalization.
ICON Public Limited Company average Market Capitalization for the last 52 weeks is USD 18.59 B.

Daily

From:

To:

Zoom:

Key data

Date	Market Capitalization	Share Price	Share Price	Price to Earnings Ratio (P/E)

NasdaqGS: ICLR

ICON Public Limited Company

CEO	Dr. Steven A. Cutler MBA, Ph.D.
IPO Date	May 15, 1998
Location	Ireland
Headquarters	South County Business Park
Employees	41,250
Sector	🏥 Health Care
Industries Clinical Trials 🧬 Biotechnology 💻 Telehealth

Description

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.

Similar companies

BSX

Boston Scientific Corporation

USD 101.37

-0.35%

SHL.DE

Siemens Healthineers AG

USD 52.28

-0.72%

RGC

Regencell Bioscience Holdings Limited

USD 63.35

-18.78%

GEHC

GE HealthCare Technologies Inc.

USD 71.89

1.05%

NTRA

Natera, Inc.

USD 170.98

2.05%

Laboratory Corporation of America Holdings

USD 261.39

0.75%

BAX

Baxter International Inc.

USD 29.80

-0.40%

TORNTPHARM.NS

Torrent Pharmaceuticals Limited

USD 37.02

-0.84%

ASND

Ascendis Pharma A/S

USD 170.71

-1.27%

EXAS

Exact Sciences Corporation

USD 52.34

-0.38%

CTEC.L

ConvaTec Group Plc

USD 3.78

-1.54%

300832.SZ

Shenzhen New Industries Biomedical Engineering Co., Ltd.

USD 8.13

1.47%

Guardant Health, Inc.

USD 50.57

2.10%

DIA.MI

DiaSorin S.p.A.

USD 107.42

0.15%

3347.HK

Hangzhou Tigermed Consulting Co., Ltd.

USD 4.62

-2.91%

688617.SS

APT Medical Inc.

USD 55.86

-1.12%

LNTH

Lantheus Holdings, Inc.

USD 78.99

1.37%

ADMA

ADMA Biologics, Inc.

USD 18.13

-4.02%

TMDX

TransMedics Group, Inc.

USD 124.00

-8.96%

LAURUSLABS.NS

Laurus Labs Limited

USD 7.65

-0.51%

IPCALAB.NS

Ipca Laboratories Limited

USD 15.69

-0.44%

INSP

Inspire Medical Systems, Inc.

USD 129.70

1.93%

600566.SS

Hubei Jumpcan Pharmaceutical Co., Ltd.

USD 3.83

-0.78%

002603.SZ

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

USD 1.97

-1.31%

PFIZER.NS

Pfizer Limited

USD 67.12

0.15%

ERIS.NS

Eris Lifesciences Limited

USD 20.65

0.27%

300676.SZ

BGI Genomics Co., Ltd.

USD 6.81

-2.56%

LIVN

LivaNova PLC

USD 45.17

1.85%

300529.SZ

Jafron Biomedical Co.,Ltd.

USD 2.90

-1.38%

VIMIAN.ST

Vimian Group AB (publ)

USD 4.14

-1.89%

VCYT

Veracyte, Inc.

USD 26.82

0.22%

BAVA.CO

Bavarian Nordic A/S

USD 27.04

0.66%

NVCR

NovoCure Limited

USD 16.80

-3.61%

VITR.ST

Vitrolife AB (publ)

USD 14.50

-0.39%

QDEL

QuidelOrtho Corporation

USD 28.33

1.07%

HRMY

Harmony Biosciences Holdings, Inc.

USD 32.48

0.03%

0853.HK

MicroPort Scientific Corporation

USD 0.97

-3.65%

603882.SS

Guangzhou Kingmed Diagnostics Group Co., Ltd.

USD 3.82

-2.33%

CERT

Certara, Inc.

USD 10.57

0.00%

INDGN.NS

Indegene Limited

USD 6.75

-0.50%

688289.SS

Sansure Biotech Inc.

USD 2.78

-1.05%

002287.SZ

Tibet Cheezheng Tibetan Medicine Co., Ltd.

USD 3.05

-1.54%

002020.SZ

Zhejiang Jingxin Pharmaceutical Co., Ltd.

USD 1.86

-1.31%

ARQT

Arcutis Biotherapeutics, Inc.

USD 13.67

3.09%

300026.SZ

Tianjin Chase Sun Pharmaceutical Co.,Ltd

USD 0.52

-1.89%

ADPT

Adaptive Biotechnologies Corporation

USD 10.47

3.25%

BHVN

Biohaven Ltd.

USD 14.39

-1.17%

605507.SS

Guobang Pharma Ltd.

USD 2.76

-1.10%

ABBV

AbbVie Inc.

USD 185.49

0.01%

NOVO-B.CO

Novo Nordisk A/S

USD 74.11

-1.13%

StockViz Staff

June 20, 2025

Any question? Send us an email